HTLV: a stigmatizing infection?

Area of Science:

• Virology
• Public Health
• Social Sciences

Background:

• Human T-lymphotropic virus (HTLV) is a significant public health concern, with Brazil having the world's largest absolute number of cases.
• An estimated 700,000 to 2 million Brazilians are infected, many as asymptomatic carriers.
• HTLV infection can lead to serious conditions like tropical spastic paraparesis, leukemia, and lymphoma.

Purpose of the Study:

• To discuss the concept of stigma associated with HTLV.
• To analyze the repercussions of stigma on individuals living with HTLV.
• To highlight the need for public policies to mitigate stigmatization and protect rights.

Main Methods:

• Literature review on stigma and HTLV.
• Analysis of authors' clinical experience with HTLV-affected individuals.

Main Results:

• Both HTLV carrier status and HTLV-related illnesses are stigmatizing.
• Stigma leads to feelings of inferiority, prejudice, and negative stereotypes.
• Stigmatization negatively impacts healthcare access, treatment adherence, and the pursuit of rights.

Conclusions:

• Stigma surrounding HTLV infection creates significant social and health challenges.
• Public policies are essential to combat stigma, ensure rights, and support individuals with HTLV.
• Empowering individuals with HTLV to exercise their civil rights is vital for their well-being.